Commonwealth of Virginia Research Consortium Authority; created. (HB2550)

Introduced By

Del. Chris Jones (R-Suffolk) with support from co-patron Del. Mark Sickles (D-Alexandria)

Progress

✓	Introduced
✓	Passed Committee
✓	Passed House
✓	Passed Senate
☐	Signed by Governor
☐	Became Law

Description

Research and development in the Commonwealth. Creates the Commonwealth of Virginia Research Consortium Authority (the Consortium) to oversee and support research and commercialization in the Commonwealth. The Consortium will be advised by an Investment Advisory Committee and a Research and Technology Advisory Committee. Existing grant, loan, and investment funds currently administered by the Innovation and Entrepreneurship Investment Authority and the Virginia Research Investment Committee would be consolidated under the Consortium, and the Consortium would be responsible for the Commonwealth Research and Technology Strategic Roadmap. The Consortium would also be responsible for allocating research-related funds to the Virginia Biosciences Health Research Consortium and the Commonwealth Center for Advanced Manufacturing. The bill repeals the existing Virginia Research Investment Committee and the Innovation and Entrepreneurship Investment Authority. The Center for Innovative Technology would move under the authority of the Consortium. A stakeholder group would be appointed to oversee the transition to the Consortium, and the Governor would be authorized to appoint an interim chief executive officer of the Consortium based upon the recommendations of the stakeholder group. Amends § 2.2-204, § 2.2-2219, § 2.2-2220, § 2.2-2221, § 2.2-2221.1, § 2.2-3705.6, § 2.2-3711, of the Code of Virginia. Read the Bill »

Status

02/14/2019: Passed the Senate

History

Date	Action
01/09/2019	Committee
01/09/2019	Prefiled and ordered printed; offered 01/09/19 19102428D
01/09/2019	Referred to Committee on Appropriations
01/15/2019	Assigned App. sub: Commerce, Agriculture, Natural Resources & Technology
01/30/2019	House subcommittee amendments and substitutes offered
01/30/2019	Subcommittee recommends reporting with substitute (8-Y 0-N)
01/31/2019	Impact statement from DPB (HB2550)
02/01/2019	House committee, floor amendments and substitutes offered
02/01/2019	Reported from Appropriations with substitute (21-Y 0-N) (see vote tally)
02/01/2019	Committee substitute printed 19106313D-H1
02/03/2019	Read first time
02/04/2019	Read second time
02/04/2019	Committee substitute agreed to 19106313D-H1
02/04/2019	Engrossed by House - committee substitute HB2550H1
02/05/2019	Read third time and passed House BLOCK VOTE (99-Y 0-N)
02/05/2019	VOTE: BLOCK VOTE PASSAGE (99-Y 0-N) (see vote tally)
02/06/2019	Constitutional reading dispensed
02/06/2019	Referred to Committee on Finance
02/12/2019	Reported from Finance with substitute (15-Y 0-N) (see vote tally)
02/12/2019	Committee substitute printed 19106829D-S1
02/13/2019	Constitutional reading dispensed (39-Y 0-N) (see vote tally)
02/14/2019	Passed Senate with substitute
02/14/2019	Passed Senate (40-Y 0-N) (see vote tally)
02/14/2019	Read third time
02/14/2019	Reading of substitute waived
02/14/2019	Committee substitute agreed to 19106829D-S1
02/14/2019	Engrossed by Senate - committee substitute HB2550S1
02/14/2019	Passed Senate with substitute (40-Y 0-N) (see vote tally)
02/18/2019	Placed on Calendar
02/18/2019	Senate substitute rejected by House 19106829D-S1 (0-Y 98-N)
02/18/2019	VOTE: REJECTED (0-Y 98-N) (see vote tally)
02/19/2019	Senate insisted on substitute (40-Y 0-N)
02/19/2019	Senate requested conference committee
02/19/2019	Impact statement from DPB (HB2550S1)
02/20/2019	House acceded to request
02/20/2019	Conferees appointed by House
02/20/2019	Delegates: Jones, S.C., Knight, Torian